Author | Year | Nation | CPM | PT | Age (Mean ± SD) | Sex, Men (%) | Outcomes |
---|---|---|---|---|---|---|---|
Joshi et al. [24] | 2015 | American | 50 | 50 | CPM: 68.5 ± 7.8 PT : 70.5 ± 8.7 | CPM: 40% PT : 24% | ROM; Complication; WOMAC; PAQ scores; Discharge location; Cost; |
Lenssen et al. [8] | 2008 | Netherlands | 30 | 30 | CPM: 64.1±8.1 PT : 65±9.1 | CPM: 40% PT : 30% | ROM-active knee flexion; ROM-passive knee flexion ROM-active knee extension; ROM-passive knee extension Pain, function (WOMAC, Knee Society Score); Pain medication; Satisfaction with treatment; Satisfaction with treatment results; Compliance; Quantity, duration and kind of treatment; |
Mau-Moeller et al [26] | 2014 | Germany | 19 | 19 | CPM: 67.1 ±8.8 PT : 68.8 ±8.0 | CPM: 63% PT : 53% | passive knee flexion range of motion; active knee flexion range of motion; active and passive knee extension ROM; static postural control; physical activity; pain; length of hospital stay as well as clinical; functional and quality-of-life outcomes (SF-36, HSS and WOMAC scores); |
Schulz et al. [25] | 2018 | Germany | 38 | 38 | CPM: 71.0± 8.0 PT : 69.0 ± 8.0 | CPM: 44% PT : 52% | Pre-op Flexion; Discharge; Length of stay in days; |
Gil‑González et al.[23] | 2022 | Spain | 105 | 115 | CPM: 74.2±6.8 PT : 73.3±6.9 | CPM: 36% PT : 39% | ROM-active knee flexion; ROM-passive knee flexion ROM-active knee extension; ROM-passive knee extension Pain medication; |
Bruun-olsen et al. [22] | 2009 | Norway | 30 | 33 | CPM: 68.0±10.0 PT : 71.0±10.0 | CPM: 27% PT : 33% | Knee circumference; Pain intensity (VAS 0 – 100); Active knee flexion; Passive knee flexion; Active knee extension; Time Up and Go;40 m walking test; |